Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1766140 · FYE Dec 31 · Prices AT CLOSE 2026-08-19 (USD) Last $5.58 · Day −0.89% · Mkt cap $157M · 1Y +37.1% · Off 52W high −36.2% · Vol (1Y) 78.8% Price2023-08-21 → 2026-08-19 UNCY close: $8.2 on 2023-08-21 to $5.6 on 2026-08-19. Split-adj closes · 240 of 1,146 · price returnⓘ At a glance | Short interest15.5% of sh out | | Days to cover5.1d | | 13F net flow (QoQ)+2.46% | | Top-10 13F concentration79.5% | | Next report (est.)2026-11-12 |
SI 2026-07-31 · 13F 2026-Q1ⓘ Key fundamentalsFY 2025 | Earnings (TTM)-$35.2M | | ROE−141.1% |
FY ratios · TTM sales/earnings (USD)ⓘ Trailing returns | YTD−3.3% | | 1Y+37.1% | | 3Y−31.9% | | 5Y−77.4% | | Since incept. (ann.)−31.4% |
Total return · from 2021-07-14ⓘ Risk | Ann. volatility (1Y)78.8% | | Ann. volatility (3Y)100.0% | | Sharpe (1Y)0.83 | | Sharpe (3Y)0.39 | | Max drawdown (1Y)−45.2% | | Max drawdown (3Y)−86.8% | | Beta (3Y vs SPY)0.60 |
Daily returns, ann.ⓘ Top institutional holders13F 2026-Q1 | Manager | Shares | Value | % sh out | QoQ |
|---|
| Vivo Capital, LLC | 1.8M | $12M | 7.09% | +0.0% | | MILLENNIUM MANAGEMENT LLC | 1.4M | $9M | 5.54% | +37.9% | | Octagon Capital Advisors LP | 1.0M | $7M | 3.96% | +0.0% | | Nantahala Capital Management, LLC | 939,202 | $6M | 3.72% | +0.0% | | VANGUARD CAPITAL MANAGEMENT LLC | 811,430 | $5M | 3.22% | new | | GREAT POINT PARTNERS LLC | 796,558 | $5M | 3.16% | +0.0% | | Logos Global Management LP | 473,563 | $3M | 1.88% | +0.0% | | CITADEL ADVISORS LLC | 236,841 | $2M | 0.94% | −8.3% |
Δ vs 2025-Q4ⓘ Latest reported quarterslast report 2026-08-12 | Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|
| 2026-06-30 | 2026-08-12 | −$0.06 | — | — | — | | 2026-03-31 | 2026-05-12 | −$0.54 | — | — | — | | 2025-09-30 | 2025-11-12 | −$0.33 | — | — | — | | 2025-06-30 | 2025-08-14 | −$0.52 | — | — | — |
As-reported XBRL · next 2026-11-12 est.ⓘ Basis & disclosures - EOD closes · nothing imputed or averaged · absent “—”
- As-of differs by block · 13F = US long, 45+d lag, LOWER bound
- Not investment advice · no recommendation, price target or solicitation
- EDGAR + foreign registers · marketstack (licensed EOD) · spzco.com/methodology
|
